ReviewPest management science2026
RNA interference in crop protection: opportunities and challenges during the transition to commercialization.
Review in Pest management science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Toward Sustainable Crop Production in a Changing Climate: Microbiomes, Pathogens, Biostimulants and Biocontrol Innovations.Microbial biotechnology · 2026Review
- Functional Characterization of Trypsin Genes inInsects · 2026Article
- Nano-enabled spray-induced RNA interference against fungal pathogens of oilseed crops: carrier performance, delivery evidence and field translation.World journal of microbiology & biotechnology · 2026Review
- Advances in the Control of Plant Fungal Pathogens.Journal of fungi (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
RNA interference (RNAi) has emerged as a promising tool for crop protection, offering the potential for high specificity and the ability to target a wide range of pests and pathogens through sequence-specific design. Growing interest from academia has accelerated research in the field, while some companies have seized the opportunity to develop RNAi-based products in regulatory environments more open to this type of innovation, positioning RNAi as a potential alternative or complement to conventional plant protection products. Notably, the recent registration of double-stranded RNA (dsRNA)-based products for insect control marks a transition from experimental research to early commercialization. However, several challenges remain before widespread adoption, especially in Europe. These include regulatory uncertainties, high production costs of dsRNA (used to trigger RNAi), limited comparative field efficacy data, and societal concerns related to emerging biotechnologies. Furthermore, broader validation is needed for environmental risk assessment. Despite these obstacles, RNAi has strong potential to enhance crop protection under climate change and delay resistance, especially when integrated with other technologies. Continued research, cost-effective production methods, and strong collaborations between academia, industry and regulators are essential to support responsible implementation, potentially improving access to advanced plant protection tools for smallholders and vulnerable farming communities. © 2026 The Author(s). Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.